HealthDay Reports: Chinese COVID Vaccine Promising in Early Trial in People
It used a weakened common cold virus to safely deliver COVID-19 coronavirus genetic material into human cells.
FRIDAY, May 22, 2020 (HealthDay News) -- Another COVID-19 vaccine candidate has achieved good early results, a research team in China reported Friday.
The experimental vaccine produced important signs of immune response in a small group of adults, a sign that it could potentially protect people against COVID-19, researchers reported May 22 online in The Lancet medical journal.
"These results represent an important milestone," researcher Wei Chen, part of a team with the Beijing Institute of Biotechnology, said in a journal news release.